LRCX
Lam Research Corporation
LRCX's outlook is improving, though it still trails on the overall score.
MU
Micron Technology, Inc.
MU has the edge over LRCX overall, supported by stronger valuation and stronger fundamentals.
LRCX Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
LRCX's revenue, profitability, cash flow and balance sheet are all currently strong.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
LRCX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $109 | -53% |
| Forward | 23x | $234 | — |
| Fair | 24x | $161 | -31% |
| Expensive | 35x | $236 | +0.9% |
| Current | 35x | $234 | — |
Historical ranges are pointers, not guarantees.
LRCX's PE is in its expensive range at 35x. If earnings grow as analysts expect, today's price would be 23x next year's earnings, in its fair range.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU has the edge over LRCX in the historical PE scenario, which offers more potential upside but is not a forecast.
LRCX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for LRCX, with profitability improving.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
LRCX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.20 | +52% |
| Q3 2026 | $6.71 | +48% |
| Q2 2026 | $5.76 | +39% |
| Q1 2026 | $5.29 | +47% |
| Q4 2025 | $4.87 | +48% |
| Q3 2025 | $4.53 | +47% |
| Q2 2025 | $4.15 | +43% |
| Q1 2025 | $3.59 | +32% |
| Q4 2024 | $3.29 | +27% |
LRCX's earnings per share have climbed steadily: $6.71 over the past year, up 48% from the year before, and higher year over year for nine quarters in a row.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU's earnings per share have climbed steadily: $74.33 over the past year, about 10 times what it earned the year before, and higher year over year for 10 quarters in a row.
LRCX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +54% |
| Q2 2026 | $6.7B | +30% |
| Q1 2026 | $5.8B | +24% |
| Q4 2025 | $5.3B | +22% |
| Q3 2025 | $5.3B | +28% |
| Q2 2025 | $5.2B | +34% |
| Q1 2025 | $4.7B | +24% |
| Q4 2024 | $4.4B | +16% |
LRCX's revenue has grown year over year for 10 quarters in a row: $8.2B last quarter, up 54% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | +5.6 points |
| Q2 2026 | 37% | +3.7 points |
| Q1 2026 | 35% | +1.9 points |
| Q4 2025 | 34% | +3.4 points |
| Q3 2025 | 34% | +4 points |
| Q2 2025 | 34% | +4.6 points |
| Q1 2025 | 33% | +5.2 points |
| Q4 2024 | 30% | +2.4 points |
LRCX's operating margin was 40% last quarter, up 5.6 points from the same quarter a year ago, near the top of its range since 2019.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over LRCX on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over LRCX on profitability, with a higher operating margin.
LRCX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.2B | +103% |
| Q2 2026 | $1.3B | -47% |
| Q1 2026 | $809.8M | -21% |
| Q4 2025 | $1.2B | +120% |
| Q3 2025 | $1.6B | +9.3% |
| Q2 2025 | $2.4B | +213% |
| Q1 2025 | $1B | -20% |
| Q4 2024 | $553.6M | -59% |
LRCX's free cash flow has been positive every quarter for seven years: $6.5B over the past year, up 18% from the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over LRCX on cash flow, with more consistent year-over-year improvement.
LRCX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -5.3M shares |
| 1 year | -1.1% | -13.5M shares |
| 3 years | -5.7% | -75.9M shares |
| 5 years | -12% | -170M shares |
| Available history | -16% | -245M shares |
LRCX has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1B |
| Q2 2026 | $246.6M |
| Q1 2026 | $1.2B |
| Q4 2025 | $1.5B |
| Q3 2025 | $975.8M |
| Q2 2025 | $1.3B |
| Q1 2025 | $435.3M |
| Q4 2024 | $697.7M |
LRCX spent $3.9B buying back its own shares over the past year, up 15% from the year before.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
LRCX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.4x | Net Cash |
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.2x | Net Cash |
| Q4 2024 | -0.1x | Net Cash |
LRCX has the edge over MU on leverage, with a lower net debt burden relative to earnings.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
LRCX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.5 | Neutral |
| Stochastic | 16.7 | Oversold |
LRCX's weekly RSI is 43 (neutral) and its Stochastic is 17 (oversold).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
LRCX PE vs Technology Sector
| Metric | LRCX | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 28x | 25% above |
| PE % | 82 | 35 | 47 pts above |
LRCX is trading at 35x earnings, a 25% premium to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over LRCX on valuation relative to its sector.
LRCX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $268.6 | 13% below |
| 20 week MA | $295.8 | 21% below |
| 50 week MA | $267.5 | 13% below |
| 100 week MA | $182.7 | 28% above |
| 200 week MA | $128.3 | 82% above |
LRCX has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 82% above its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has the edge over LRCX on trend strength, trading above more of its moving averages.
LRCX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.4 | $48.0 | +64% |
| 2021 | $48.0 | $69.9 | +45% |
| 2022 | $69.9 | $41.2 | -41% |
| 2023 | $41.2 | $78.3 | +90% |
| 2024 | $78.3 | $73.4 | -6.3% |
| 2025 | $73.4 | $178.1 | +143% |
| 2026 YTD | $178.1 | $233.8 | +31% |
LRCX's yearly returns have swung widely, from +143% in 2025 to −41% in 2022. It's up 31% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over LRCX on returns for 2026, with the stronger performance.